The Clinical Evaluation of Third-generation Cephalosporins As Definitive Therapy for Enterobacter spp. and Klebsiella aerogenes Bacteremia

OBJECTIVE: Third-generation cephalosporins (3GCs) may be susceptible in vitro to Enterobacter spp. and Klebsiella aerogenes. However, treatment with mainly fourth-generation cephalosporins or carbapenems is currently recommended. Diversification of antimicrobial agents in therapy is required to avoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Kazuhiro, Hata, Atsuko, Imoto, Waki, Kakuno, Shigeki, Shibata, Wataru, Yamada, Koichi, Kawaguchi, Hiroshi, Sakurai, Norihiro, Nakaie, Kiyotaka, Nakatsuka, Yukari, Ito, Toshikazu, Uenoyama, Kazuya, Takahashi, Tamotsu, Ueda, Satoru, Katayama, Toshiro, Onoue, Masahide, Kakeya, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372282/
https://www.ncbi.nlm.nih.gov/pubmed/36384899
http://dx.doi.org/10.2169/internalmedicine.0612-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372282/
https://www.ncbi.nlm.nih.gov/pubmed/36384899
http://dx.doi.org/10.2169/internalmedicine.0612-22

Ejemplares similares